Indonesian Political, Business & Finance News

Development of Phytochemical and Health-Based Medicinal Plants

| | Source: Republika Translated from Indonesian | Economy
Development of Phytochemical and Health-Based Medicinal Plants
Image: Republika

Indonesia’s geographical location in the tropics, flanked by two continents and two oceans, provides climatic conditions highly conducive to the growth of diverse flora. It is estimated that there are around 30,000 plant species in Indonesia, with more than 9,600 of them known to possess medicinal properties. However, only about 300 species are widely utilised in the traditional and modern medicine industries (Ministry of Health, 2017). This potential indicates that Indonesia’s biodiversity is a strategic resource that can be developed into phytochemical raw materials with economic value while supporting national health resilience.

Biodiversity is not only understood as the large number of species living in an area but also encompasses genetic diversity, ecosystems, and ecological interactions that form nature’s balance. Indonesia has various ecosystem types, ranging from tropical rainforests, mountains, peat swamps, and savannas to coastal and mangrove areas. This ecosystem diversity allows for the growth of various plant types that produce secondary metabolites with unique chemical structures. Secondary metabolite compounds such as alkaloids, flavonoids, terpenoids, saponins, tannins, and phenolics are the main components widely used in the development of herbal medicines and modern pharmaceuticals (Harborne, 1998).

The vast potential of medicinal plants in Indonesia is also supported by a wealth of traditional knowledge passed down through generations. Various ethnic groups in Indonesia have their own ways of using plants as medicine to treat various diseases. This local knowledge is part of cultural wisdom that has been proven to support public health services for a long time. The tradition of using jamu in Java, the medicinal concoctions of the Dayak people in Kalimantan, the traditional medicine of the Minangkabau community, and the use of medicinal plants by the people of Papua are clear examples that Indonesia’s biodiversity has been part of social life for centuries (Elfahmi et al., 2014).

From a phytochemical perspective, Indonesian medicinal plants hold great opportunities as a source for discovering new bioactive compounds. Various studies show that many local plants have promising biological activities, such as antioxidant, anticancer, antidiabetic, antimicrobial, anti-inflammatory, and antiviral properties. For example, turmeric (Curcuma longa) contains curcumin, which has anti-inflammatory and antioxidant activity; sambiloto (Andrographis paniculata) contains andrographolide, which has the potential to boost the immune system; while pasak bumi (Eurycoma longifolia) is known to contain quassinoids useful as an immunomodulator and natural tonic (Ministry of Health, 2017). Research on these various species shows that Indonesia’s floral wealth is not only important for traditional medicine but also has great prospects in the development of modern natural-based drugs.

Beyond its health benefits, Indonesia’s biodiversity also contributes to national economic development. The herbal medicine, natural cosmetics, functional foods, and health supplement industries have experienced rapid growth in recent years. Increasing public awareness of healthy lifestyles is driving demand for natural-based products. This condition presents an opportunity for Indonesia to develop the downstream processing of phytochemical research results, thereby not only selling raw materials but also producing high-value-added products capable of competing in the international market (Bappenas, 2016).

Nevertheless, the utilisation of Indonesia’s biodiversity still faces various challenges. One of the main problems is the high rate of forest destruction due to land conversion, illegal logging, forest fires, and climate change, which threaten the sustainability of various medicinal plant species. Many high-potential endemic plants that have not yet been scientifically studied have experienced population declines and are even threatened with extinction. This condition indicates that conservation efforts must go hand in hand with the utilisation of biological resources to maintain ecosystem sustainability (KLHK, 2021).

Another challenge is the limited phytochemical research capable of comprehensively identifying the active compound content in local plants. Most research is still at the initial exploration stage, necessitating collaboration between universities, research institutions, the pharmaceutical industry, and the government to accelerate the innovation process. The development of extraction technology, active compound isolation, toxicity testing, and clinical trials are important stages for Indonesian medicinal plants to be accepted as health products meeting international standards (WHO, 2013).

On the other hand, advances in biotechnology, bioinformatics, metabolomics, and artificial intelligence open new opportunities to accelerate the discovery of bioactive compounds from Indonesian plants. Modern technology allows the process of identifying secondary metabolites to be carried out more quickly and accurately, thereby increasing research efficiency. The integration of phytochemistry with molecular biology also accelerates the development of safer and more effective natural resource-based drugs. With government policy support through the development of national biopharmaceuticals, Indonesia has a great opportunity to become a centre for tropical medicinal plant research in the Southeast Asian region (BRIN, 2023).

More from 14 July 2026 →

Cite this article
Source: jawawa.id (https://jawawa.id/newsitem/development-of-phytochemical-and-health-based-medicinal-plants-1783997503)
Originally published by Republika (https://retizen.republika.co.id/posts/770902/pengembangan-tumbuhan-obat-berbasis-fitokimia-dan-kesehatan), translated from Indonesian
Print